[Immunomodulatory therapy of epilepsy with transfer factor]
[Article in Slovak]
Simko M, Mokrán V, Nyulassy S.
Zdruzené lekársko-imunologické pracovisko Ustavu preventívnej a klinickej medicíny a Dérerovej Nemocnice a poliklinikou v Bratislave, Slovakia.
Effect of immunotherapy with Transfer factors administered for a period of three months was studied in a group of ten epileptic patients, treated with carbamazepine or primidon previously and throughout the study. Out of eight patients, who finished the study we could notice significant reduction of epileptic discharges in eight patients. The results of this study prove that addition of immunomodulatory treatment to patients with intractable epilepsy could substantially improve the course of the disease in some patients. (Tab. 1, Fig. 5, Ref. 13.)
PMID: 9264833 [PubMed - indexed for MEDLINE]
Dialyzable Lymphocyte Extract in Infantile Onset Autism
|
Autism Spectrum Disorders: An Integrated Approach
Dr. Bock gave an insightful lecture on autism and the different areas that play a part in its diagnosis and treatment. Autism can occur as a result of various factors: genetics, neuro/immunotoxicologic factors, metals, xenobiotics (like pesticides), abnormal liver function, nutritional deficiency, gastrointestinal abnormalities and a viral infection or auto-immunity. Each of these factors is equally important in the treatment of autism.
The immune system is an important aspect of bringing balance to the body, and specifically, to someone who has autism. Transfer factors can be very effective because they have been shown to both boost and suppress the immune system. Dr. Bock recently conducted an important study on the use of transfer factors with children who have Autism Spectrum Disorders.
Transfer Factors Study with Autistic Children By Bock M.D.
9 children
ages: 2.9-9.9
average age: 5.07
These children were given three capsules containing transfer factors, three times daily, for three months. Each patient was assessed prior to the treatment, six weeks into the study, and at the completion of the three-month study. Dr. Bock used the Gilliam Autism Rating Scale for evaluation purposes. This method applies different scores based on: stereotyped "autistic" behaviors, communication, social interaction and developmental markers. These scores are then added together to determine an autism quotient. The higher the autism quotient is, the higher the degree of autism in the patient.
At the end of the three-month study, seven out of the nine autistic children had at least some improvement. Specifically, these improvements included:
- More attentive
- Eye contact improved
- Eczema improved
- Decreased incidence of illness
- Improved language skills
- Resolution of diarrhea
- Improved toileting skills
Although this study was small, Dr. Bock believes its results are very promising. He has included products with transfer factors as part of his treatment protocol and is excited about its possibilities for boosting the immune system in patients with autism as well as many other conditions he encounters on a daily basis.
Dr. Bock is a physician who is renowned for his integrated approach to health and wellness. For the past 17 years he has integrated alternative modalities with conventional medicine into what he calls Progressive Medicine.
He is the co-author of two books: The Road to Immunity and Natural Relief for your Child's Asthma.